IM specialty
research cards
The landmark trials that shape internal-medicine practice, distilled one subspecialty at a time. Each card is an at-a-glance infographic — and below it, every study is linked to its primary publication with a brief, plain-language summary of what it showed and why it matters. Built for the ward, the board exam, and the quick refresher.
Cardiology
ACS foundations, HFrEF and HFpEF, atrial fibrillation, lipid lowering, revascularization, and structural heart disease.
Open the card → Landmark trialsEndocrinology & Diabetes
Glycemic control, cardiovascular-outcome trials, thyroid, adrenal, and bone.
Open the card → Landmark trialsGastroenterology & Hepatology
IBD, GI bleeding, hepatology, and endoscopic intervention.
Open the card → Landmark trialsHematology
Anticoagulation, anemia, thrombosis, and transfusion.
Open the card → Landmark trialsInfectious Diseases
Antimicrobial stewardship, sepsis, HIV, and pathogen-directed therapy.
Open the card → Landmark trialsNephrology
CKD progression, glomerular disease, dialysis, and the SGLT2 era.
Open the card → Landmark trialsOncology
Precision therapy, immunotherapy, and supportive care.
Open the card → Landmark trialsPulmonary & Critical Care
ARDS, mechanical ventilation, asthma/COPD biologics, and sepsis.
Open the card → Landmark trialsRheumatology
Treat-to-target, targeted biologics, and vasculitis.
Open the card →